Best Neurology Companies in Netherlands
The 38 best Neurology companies in Netherlands in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: VectoryTx.
- Neurology Market Expected to Witness Sustained Growth
Our analysis of 50 Neurology companies
$7.4b in tracked funding; 74% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Neurology companies in Netherlands
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | VectoryTx Developer of therapeutics for neurodegenerative and muscular disorder | $176M | 34 mo ago | 78 | Sander Van Deventer Chief Executive Officer | Cart FunctionalitySquarespace CommerceSquarespace+16 | Top 10M | — | 1 job opening |
| 2 | Vico Developer of RNA modulating therapies for genetic neurological diseases | $103M | 26 mo ago | 38 | Judith Van Deutekom Scientific Co-Founder and Advisor | WordPressMySQLPHP+16 | Top 10M | — | — |
| 3 | TIBEAY Biosciences Clinical-stage biopharmaceutical company focused on developing innovative therapies for acute neurological… | $41M | 5 mo ago | — | Klaas Boer Co-Founder | — | — | — | — |
| 4 | ONWARD Developer of a therapeutic device for spinal cord injuries | $35M | 4 mo ago | 100 | Dave Marver CEO | DrupalApple iCloud MailMicrosoft 365+26 | Top 10M | — | — |
| 5 | Salvia BioElectronics Developing bioelectronic solutions for individuals suffering from migraines and other neurological disorders | $34M | 15 mo ago | — | Wim Pollet Founder & Chief Medical Officer | WebflowGSAPCloudflare Turnstile+12 | Top 10M | 72 patents Implantable neurostimulation devices with wireless power and advanced electrode array technologies | — |
| 6 | SentryX Developer of therapeutics for pain treatment after surgery | $17M | 41 mo ago | 20 | Bas Oosterman Co-Founder and CEO | TurbopackNode.jsReact+11 | Top 50M | 44 patents Gelatin-based pharmaceutical excipients and hydrogel drug delivery technologies | 1 award |
| 7 | Neuroplast Developer of neuro-regenerative medicines for patients | $16M | 44 mo ago | 29 | Johannes De Munter CEO | — | — | — | — |
| 8 | Alveron Pharma Developer of drugs to treat haemorrhagic stroke or intracranial haemorrhage | $12M | 59 mo ago | 3 | — | — | — | 8 patents Cyclodextrin-based hemostatic agents for rapid blood clotting | — |
| 9 | Prolira Developer of a non-invasive device for the early detection of delirium | $6M | 55 mo ago | 12 | Rutger Van Merkerk Co-Founder & CEO | — | — | 17 patents EEG electrode carriers and signal classification systems for neurophysiological monitoring | — |
| 10 | STIL Developer of a wearable device for tremor suppression | $5M | 44 mo ago | — | IJsbrand Lange Founder & CEO | — | — | 8 patents Orthopedic wearable braces for body support and joint stabilization | — |
| 11 | MindAffect Manufacturer and developer of industrial robots | $2M | 28 mo ago | 10 | Ivo Box Co-Founder & CEO | WixSentryBootstrap+15 | Top 50M | 10 patents Assessing sensory capabilities using bioelectrical electrode sensing for health diagnostics | — |
| 12 | TMS International Electrodiagnostic technology platforms | $1M | 47 mo ago | 45 | Leo Hoogendoorn CEO | — | — | — | — |
| 13 | Amylon Developer of RNA therapeutics for rare beta-amyloid related diseases | $348K | 106 mo ago | 2 | Daniel de Boer Co-Founder | — | — | — | — |
| 14 | Treeway Co-developing immunotherapy drugs for Amyotrophic lateral sclerosis (ALS) | $111K | 136 mo ago | — | Bernard Muller Founder & Solutionist | — | — | — | — |
| 15 | NightWatch Provider of wearable device for epilepsy seizure detection during sleep | $110K | 77 mo ago | 3 | Mark Bloemendaal Co-Founder | Cart FunctionalityWordPressMySQL+23 | Top 5M | — | — |
Top 12 Neurology companies in Netherlands
#1
Public · Eindhoven, North Brabant · founded 2014 · 100 employees$35Mraised▾
Developer of a therapeutic device for spinal cord injuries. The company's ARC therapy is delivered by implantable or external systems as programmed stimulation of the spinal cord that helps restore movement and other functions associated with the spinal cord.
- Apr 2026Post IPO$47.9M
- Oct 2025Post IPO$59.2M
- Nov 2024Grant (prize money)—
- Oct 2024Post IPO$24.3M
#2
Series C · Nijmegen, Gelderland · founded 2025$41.2Mraised▾
Clinical-stage biopharmaceutical company focused on developing innovative therapies for acute neurological conditions. The company focuses on developing therapies for acute neurological conditions. Its lead compound, Ronopterin, a selective iNOS inhibitor, for severe traumatic brain injury. It aims to reduce secondary brain injury, a condition with no approved pharmacological treatment.
- Apr 2026Series C$41.2M
#3
Series B · Eindhoven, North Brabant · founded 2017$34.3Mraised▾
Developing bioelectronic solutions for individuals suffering from migraines and other neurological disorders. It aim to eenhance the quality of life for migraine sufferers through its neuromodulation therapy. It has developed a paper-thin implant designed to reduce the frequency and intensity of migraine attacks by delivering gentle electrical pulses to the nerves associated with migraines.
- May 2025Series B$60M
- Sep 2020Series A$24.8M
- Sep 2020Conventional Debt$5.9M
- Apr 2019Series A$2.1M
#4
Series B · Leiden, South Holland · founded 2019 · 38 employees$103.3Mraised▾
Developer of RNA modulating therapies for genetic neurological diseases. The company uses VICOMER antisense oligonucleotide platform to design RNA modulating therapeutics to address specific genetic defects such as Rett syndrome, Alzheimer’s disease, Huntington disease, and more. The company's lead candidate is VO659 for multiple polyglutamine disorders, spinocerebellar ataxia type 3 and type 1 and Huntington’s disease.
- Jun 2024Series B$12.3M
- Jan 2024Series B$60M
- Jul 2020Series A$31M
#5
Series A · Amsterdam, North Holland · founded 2020 · 78 employees$175.6Mraised▾
Developer of therapeutics for neurodegenerative and muscular disorders. The products contain next-generation viral vectors that target specific cell types and subcellular compartments while evading the host immune response. The company is developing therapeutics based on an AAV gene therapy platform, antibody, and RNA-targeted degradation technologies.
- Nov 2023Series A$138M
- Jun 2021Seed$37.6M
#6
Funding Raised · Woudenberg, Utrecht · founded 2017 · 20 employees$16.7Mraised▾
Developer of therapeutics for pain treatment after surgery. The company's lead product BR-003 is a highly elastic and biodegradable hydrogel designed to be attached to commercially available screws used in spinal surgery.
- Apr 2023Grant (prize money)$16.7M
#7
Series B · Geleen, Limburg · founded 2014 · 29 employees$15.8Mraised▾
Developer of neuro-regenerative medicines for patients. The company's lead product Neuro-Cells is an autologous stem cell treatment that aims to reduce irreversible impact and injury to the nerve system.
- Jan 2023Grant (prize money)$187.5K
- Nov 2021Series B$11.5M
- Mar 2021Grant (prize money)$144K
- Feb 2020Series A$4.3M
#8
Series A · Nijmegen, Gelderland · founded 2017 · 10 employees$2.4Mraised▾
Manufacturer and developer of industrial robots. It supports communication and interaction for locked-in patients. The device is a headset that measures the electrical brain signals to control a computer for communicating using the brain-computer interface. The device doesn't need any training and can be controlled well with continuous use.
- Apr 2024Series A$1.2M
- Sep 2021Series A—
- Jul 2019Grant (prize money)$56.4K
- May 2018Seed$1.2M
#9
Series A · Nijmegen, Gelderland · founded 2019 · 3 employees$11.8Mraised▾
Developer of drugs to treat haemorrhagic stroke or intracranial haemorrhage. The company is focused on developing a drug called OKL-1111, which is being positioned as a rapid, first-line therapy for intracranial hemorrhage (ICH).
- Oct 2021Conventional Debt—
- Oct 2021Series A$4.5M
- May 2019Series A$7.3M
#10
Seed · Delft, South Holland · founded 2016$5Mraised▾
STIL is developing a wearable device for suppressing tremors in patients with Parkinson's disease and essential tremors. The anti-tremor brace is worn around the wrist that helps provide patients with a steady hand to suppress involuntary shakes or tremors. Some of the partners are atHealth, Rabobank, and Reiner de Graaf.
- Jan 2023Grant (prize money)$5M
- Nov 2017Seed—
#11
Series B · Utrecht, Utrecht · founded 2015 · 12 employees$5.7Mraised▾
Developer of a non-invasive device for the early detection of delirium. The company offers an EEG-based device that consists of a single-use electrode patch and a hardware/software module that analyses brain activity.
- Feb 2022Series B$5.7M
- Nov 2018Series A—
- Jul 2018Grant (prize money)$2.8M
- Sep 2016Seed—
#12
Funding Raised · Oldenzaal, Overijssel · founded 2000 · 45 employees$1.5Mraised▾
TMS International produces high-precision multi-channel amplifiers, data acquisition, and communication solutions, first and foremost for (electro-) physiological applications. Their technology has applications in measurement of Bioelectric signals in electrically active tissue like the heart, the muscles or the brain. For example, the technology is used to produce EEG, ECG and EMG machines to measure brain waves, heartbeat, and muscle excitement. The company offers Saga, Refa, Mobita, Mobi, and Porti which are multi-channel electrophysiological measurement devices
- Oct 2022Grant (prize money)$343.1K
- Jan 2018Grant (prize money)$306.7K
- Jun 2017Grant (prize money)$455.5K
- Mar 2016Grant (prize money)$364.8K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Neurology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Neuroscience & Neurotech is moving in the Netherlands
A read on the academic research around Neuroscience & Neurotech — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 792 Netherlands-affiliated papers.
- Maastricht University152
- University of Amsterdam150
- Amsterdam University Medical Centers113
- Radboud University Nijmegen99
- Amsterdam Neuroscience94
- Deep brain stimulation13→21
- Neuromodulation1→7
- Stimulation6→9
- Local field potential3→4
- Deep brain stimulation76→140
- Parkinson's disease22→47
- Stimulation43→66
- Neurostimulation8→22
- Brain stimulation2→15
- Neurostimulation4→13
- Brain stimulation3→9
- Randomized controlled trial1→6
- Neuromodulation1→6
- Essential tremor2→5
Where neurotech is researched across Netherlands
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.